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Hypothyroidism a quite common thyroid disorder is often associated with anemia. Osmotic fragility is altered with an 
alteration of the thyroid profile. Hypothyroidism induced reduction of membrane cholesterol and compromised the activity 
of Na+K+ATPase and increased peroxidation of membrane lipids appear to be responsible for damaging the red blood 
corpuscle (RBC) membranes which alter the permeability of themembrane and thus ionic environment within the cell. The 
objective of this study was to evaluate the relation between the association of hypothyroidism and RBC membrane lipid 
peroxidation in the development of increased RBC osmotic fragility. A complete clinical history and biochemical 
investigations, including thyroid function tests namely, thyroid stimulating hormone (TSH) and free T4 (fT4), RBC 
membrane osmotic fragility test by gradient concentration of NaCl, and RBC membrane peroxidation using thiobarbituric 
acid reactive substances (TBARS) tests were performed among thirty two hypothyroidism patients and healthy controls. 
Serum TSH & TBARS in the RBC membrane were significantly higher (P <0.001) than healthy controls which also showed 
a significant positive correlation (r =0.8, P =0.01) when compared without grouping. Osmotic fragility of RBC was found 
significantly increased among hypothyroid patients (P <0.001) at NaCl conc. of 0.3%, 0.4%, 0.5% & (P <0.05) at NaCl 
conc. of 0.6%. In conclusion, the results indicated that RBC osmotic fragility increases significantly in hypothyroidism 
possibility due to increased membrane lipid peroxidation as observed in the study. 
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Alterations in thyroid function are quite common 
clinical conditions in day to day practice. Being  
one of the major metabolic regulators such 
disturbance results in many physiological alterations. 
Hypothyroidism with low thyroid hormones and 
corresponding high TSH levels is responsible for 
negative resting energy expenditure and thus 
hypometabolism which is reflected by altered lipid 
metabolism, obesity, decreased gluconeogenesis and 
many others1. Anemia is a common clinical 
association with thyroid dysfunctions and though 
normocytic anemia is most predominant, macrocytic 
and microcytic types are also dealt with2. Increased 
hemolysis and thus reduced survival period might  
be one of the major reasons for anemia in 
hypothyroidism3 which is augmented by the altered 
lipid composition of the RBC membrane4 and  
Na+K+-ATPase activity5. RBC membrane peroxidation 
and oxidative stress were reported to be significantly 
higher among hypothyroid patients6-8 which further 
may contribute to altered membrane stability and thus 
increased hemolysis. 
Metabolic processes control ATP levels, ROS 
generation and redox state within cells and thus also 
control ion handling by pumps and passive transport 
pathways9,10. Deranged lipid metabolism alters lipid 
composition and thus membrane fluidity of various cell 
membranes including RBC in hypothyroidism5,11,12. 
Hypothyroidism-induced oxidative stress and lipid 
peroxidation13,14 may further contributes to membrane 
instability. Decreased Na+K+ATPase activity also 
alters net ion transport across the cell membrane with 
altered intra cellular ionic environment15-16. 
All these factors might play together to bring upon 
the increased hemolysis in hypothyroidism. However 
as earlier studies have ended with contradictory 
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results, hence in the present study, we evaluated the 
association of RBC osmotic fragility with 
hypothyroidism among the treatment naïve 
hypothyroidism patients. 
 
Materials and Methods 
 
Reagents 
Thyrotropin (TSH) Test System and free Thyroxine 
(fT4) from Monobind Inc (Lake Forest, USA), 
Thiobarbituric acid (TBA) from Loba Chemie, 
Ammonium molybdate, HEPES, EDTA, PMSF and 
Tris-HCl from SRL Chemical, India; All other 
chemicals used were of analytical grade and were 
purchased from the Merck India Ltd. and SRL India. 
 
Selection of participants 
For this hospital based cross sectional study 
participants were selected randomly among the 
patients attended the Department of Biochemistry, 
College of Medicine & JNM Hospital, WBUHS, 
Kalyani, Nadia for thyroid profile estimation referred 
from various OPDs of the same institute. 32 adults 
between 20 to 48 years of freshly detected treatment 
naïve patients suffering from hypothyroidism 
irrespective of sex were selected as cases. However, 
pregnant mothers, smokers, patients with a history of 
alcoholism, any concomitant chronic disease or 
patients under treatment for the same that can 
interfere with study results were excluded. The results 
obtained were compared with randomly selected 32 
adult healthy volunteers, served as controls. 
Hypothyroidism was characterized by TSH  
level (>4.2 mIU/mL) with or without fT4 level  
(<0.8 ng/dL)17,18. This study was approved by the 
Institutional Ethics Committee as per ICMR guideline 
(Ref. No. F-24/Pr/COMJNMH/IEC/16/1209 Dated 
18th August 2016).  
 
Blood sample preparation 
After obtaining the written informed consent, 7 mL 
of fasting (12 hrs) venous blood sample was collected 
from each participant and divided into 2 mL for 
thyroid profile estimation which was centrifuged and 
sera separated and kept at –200 C until analysis. 5 mL 
with EDTA (1.5 mg/mL blood) was used for the 
osmotic fragility test and lipid peroxidation (TBARS) 
estimation from the membrane ghost. 
 
Assay 
Biochemical analysis of serum TSH and fT4 were 
done by Immuno-enzymometric assay and Enzyme 
Immunoassay using 96 well microplate assays using 
kits from Monobind Inc as mentioned earlier. 
Absorbance was measured by TECAN’S Magellan 
universal reader (Sunrise) at 450 nm. 
For RBC osmotic fragility assay, cells were washed 
with 0.9% NaCl thrice. For each wash, 1.5 mL of the 
blood sample was mixed with 8.5 mL of 0.9% NaCl 
and centrifuged for 5 min at 1000 rpm. After careful 
discarding supernatant of final centrifugation cells 
were suspended in 1.5 mL of 0.9% NaCl and 50 µl of 
cell suspension was added in triplicate to the tubes 
containing 1 mL of different NaCl concentration (0-
0.9%). Tubes were incubated for 30 min at 37°C 
followed by centrifugation at 3000 rpm for 10 min. 
The absorbance of the supernatant was measured at 
540 nm using UV-VIS Spectrophotometer 117 
(Spectronics). Each concentration of NaCl was made 
in triplicate and the average of absorbance was 
accepted as a final reading. The percentage of 
hemolysis was calculated considering absorbance for 
the tube containing no NaCl as 100%19. The percent 
hemolysis was calculated using following 
formula20 
 
100 
NaCl) (No
 standard  theof Absorbance
 test  theof Absorbance hemolysisPercent   
 
Preparation of erythrocyte membranes (Ghosts) 
Cytoplasm free erythrocyte membranes were 
prepared as per the following method21,22. The blood 
concentrates were subjected to centrifugation at  
6500 × g for 10 min at 4°C. Precipitates obtained 
were resuspended in 20 mM Tris-Cl (pH 7.4), 130 mM 
KCl and 0.6 mg/ mL phenylmethylsulfonyl fluoride 
(PMSF). This suspension was centrifuged again at 
6500 × g for 10 min at 4°C. Hemolysis obtained by 
freezing cell pellets in liquid nitrogen followed by 
thawing at room temperature. The lysed cells were 
then re-suspended with 5 mM 4-2-hydroxyethyl-1- 
piperazineethanesulfonic acid (HEPES; pH 7.4),  
1 mM ethylene diamine tetra acetic acid (EDTA) and 
0.6 mg/mL PMSF and centrifuged at 9000 × g for  
10 min at 4°C. This washing step was repeated  
four times, and the resulting pellets were used for 
TBARS assay to measure malondialdehyde (MDA), 
suspended in (40 mL) 10 mM HEPES (pH 7.4),  
130 mM KCl, 0.5 mM MgCl2, and 0.05 mM CaCl2. 
The solutions were spun at 9000 × g for 10 min, 
resuspended in a small volume of this last buffer, and 
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stored at –20°C until use.  
The ghost membrane sample was thawed at room 
temperature. 1 mL sample was mixed with 2 mL 10 % 
trichloro acetic acid and 4 mL 0.67 % thiobarbituric 
acid. The mixture was heated in a water bath at 100°C 
for 15 min, cooled and centrifuged; absorbance was 
recorded at 535 nm. The extent of lipid peroxidation 
was calculated using a molar extinction coefficient of 
1.566105 M21 cm 21 for MDA23. 
 
Statistical analysis 
All results are expressed as the mean ± standard 
error (SE) using statistical software SPSS version 20. 
The significance of the difference of means was 
determined by the student’s t test. Pearson’s 
correlation analysis was performed between TSH and 
TBARS without grouping to verify the relation 
between them. A value of P <0.05 was used to 
evaluate statistical significance. For a graphical 
representation of analysis results, GraphPad Prism 
(Version 8) was used. 
 
Results 
Results obtained from the study showed that TSH 
level and TBARS were significantly increased among 
the hypothyroidism group when compared to matched 
controls (P <0.001) (Table 1).  
When the percentage of hemolysis was 
assessed between the control and cases it was 
found that at low concentrations of NaCl (0.01% 
& 0.02%) there was no significant change as 
hemolysis in both the groups. The same has been 
noted at higher concentrations of NaCl (0.07%, 
0.08% & 0.09%) where there was minimal or no 
hemolysis in both groups. However, significant 
difference in the hemolysis was noted at NaCl 
concentrations of 0.03%, 0.04% & 0.05%  
(P <0.001) and also at 0.06% (P <0.05) when 
compared between hypothyroidism cases and control 
group (Fig. 1). 
Pearson’s correlation was performed between TSH 
concentration and TBARS level considering both 
groups (Control & Cases) together and it showed that 
there was a significant positive correlation (r =0.8,  
P =0.01) between the TSH and TBARS (Fig. 2).  
Discussion 
Studies have been conducted earlier on RBC 
osmotic fragility and thyroid function with 
contradictory results. However, results obtained from 
our study showed that there was increased RBC 
osmotic fragility and increased lipid peroxidation of 
the RBC membrane among hypothyroid patients 
which is in agreement with earlier studies24-26.  
Thyroid hormones namely, triiodothyronine (T3) 
and tetraiodothyronine (T4) are synthesized in the 
thyroid gland under the regulation of thyroid 
stimulating hormone (TSH) from the pituitary27. Post 
synthesis, the hormone is released in blood to serve as 
a major regulator of metabolism and thus growth and 
development.  
When lipid metabolism is concerned in 
hypothyroid state the situation is worsened with the 
rise of serum TSH level28. Altered lipid metabolism 
results in dyslipidemia. Hypercholesterolemia and 
Table 1 — Thyroid profile & TBARS in control and 
patients with hypothyroidism 
Parameters Control (n=32) Hypothyroid (n=32) P value 
TSH (μIU/mL) 1.98±0.20 14.64±1.53 <0.001 
fT4 (ng/dL) 1.19±0.05 1.14±0.77 0.69 
TBARS (nM/mL) 3.69±0.097 5.64±0.091 <0.001 
All values are expressed as mean ± SE 
 
 
Fig 1 — Comparison of hemolysis % between control and 
hypothyroid patients 
 
 
Fig 2 — Correlation between serum TSH with RBC membrane 
TBARS (r =0.8, P =0.01) 
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increased serum LDL-C are the most prominent 
features associated with both clinically overt  
and subclinical hypothyroidism29-32. Such 
hypercholesterolemia is due to TSH dependent 
stimulation of hepatic HMG Co-A reductase enzyme, 
the major and regulatory enzyme for cholesterol 
synthesis33. However, when cell membrane lipid 
content is concerned, the scenario is quite different 
from plasma. In hypothyroidism with 60% plasma 
cholesterol increase, there is a 22% reduction in 
cholesterol in the RBC membrane. This is further 
accompanied by a 30% reduction in RBC membrane 
phospholipid content11. Recent studies have suggested 
that elevated TSH level also facilitates the transfer of 
intracellular cholesterol to extracellular apolipoprotein 
through up-regulation of ATP-binding cassette 
subfamily A members (ABCA1) expression34. This can 
explain, at least partially the serum 
hypercholesterolemia with decreased cholesterol levels 
in cell membranes among hypothyroidism patients. 
Reduction in membrane cholesterol increases cellular 
stiffness which may be the underlying cause of 
increased RBC osmotic fragility35.  
In hypothyroidism membrane cholesterol decrease 
reduces the membrane fluidity which is reflected by 
decreased activity of membranebound Na+K+ATPase4 
and alteration of membrane transport of various other 
ions and metabolites. Increased oxidative stress in 
hypothyroidism25,36 inhibits Na+K+ATPase by 
glutathionylation of β1 subunit of the enzyme and 
also by alteration of its conformation37. Inhibition of 
Na+K+ATPase induces cell lysis which has been 
already established in vitro cell culture model38. 
Suboptimal activity and failure of the Na+K+ ATPase 
can result in swelling of the cell by alteration of 
intracellular ion concentration which further may 
contribute to increased RBC lysis39.  
Though theoretically membrane cholesterol content 
does not affect cellular drug uptake40 but it has been 
shown that reduction of cholesterol content in the 
erythrocyte membrane further reduces Ca2+ transport 
across the membrane and reduces intracellular Ca2+ 
content. Ca2+ influx through the Ca2+ channel is 
reduced significantly if the membrane cholesterol 
content is decreased41. Various calcium sensors like 
synaptotagmin (Syt) VII, dysferlin and apoptosis-
linked gene-2 (ALG-2) are associated with membrane 
repair mechanism which suggests that Ca2+ may 
regulate several steps of the membrane repair process. 
Therefore, the reduction of intracellular Ca2+ may 
decrease the ability of a cell to repair its membrane 
injury42.  
Increased oxidative stress is an important finding 
among hypothyroid patients both in subclinical and 
clinically overt cases25,36. In the hypothyroid state, 
there is a significant reduction in total antioxidant 
capacity43 and decreased total reduced glutathione 
(GSH) content within RBC44. These together could 
play an important role in the development of 
oxidative stress and ultimately put the cell under risk 
of hemolysis.  
Membrane lipid peroxidation has always been a 
major concern in thyroid dysfunction which is the 
reflection of oxidative stress. Reduction in catalase 
activity has been reported in hypothyroidism45 which 
leads to the accumulation of H2O2. Excess H2O2 could 
react with NO to generate peroxynitrite and various 
other hydroxyl free radicals. These radicals could 
further react with and result in damage of cellular 
structures which is known as lipid peroxidation46,47. In 
our study we have found there is a significant increase 
of RBC membrane lipid peroxidation with increased 
serum TSH level which is in agreement with earlier 
studies8,25,43. Increased membrane lipid peroxidation 
alters lipid bilayer physiology and physiological 
properties and functions of cell membranes that result 
in the modification of proteins and even nucleic 
acids48,49. Such changes result in altered lipid-lipid 
interactions, ion transport across the cell membrane, 
membrane fluidity and membrane permeability46. It 
has been also hypothesized that when the membrane 
is deficient in cholesterol, phospholipid peroxidation 
decreases membrane thickness50.  
 
Conclusion 
This study suggested that the osmotic fragility of 
erythrocytes increases significantly in hypothyroidism. 
Augmentation of hemolysis might be the result of the 
interplay between reduced cholesterol content of cell 
membrane along with reduced membrane bound 
Na+K+ATPase activity and Ca2+ transport across the 
cell membrane. Increased membrane lipid 
peroxidation has an additive effect on thyroid 
dysfunction by altering lipid-lipid interactions, ion 
transport across the cell membrane, membrane 
fluidity and membrane permeability. 
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